Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

News

Global WholeHealth Partners, Corp (OTC: GWHP) Announces New Purchase Agreement From RyZac Health as Order Size Increases Over 3 Times

San Clemente 1/13/2021 12:00:00 PM

Global WholeHealth Partners Corp, a multinational supplier of over 70+ with 56 products FDA approved and several approved for export only including Dengue, Ebola, Zika, Malaria and also offering one of the largest lines of tests for CoViD19 SARS2, is prepared to help in the fight against CoViD19 SARS2. With the pandemic out of control in the United States, the nation's coronavirus testing system is starting to strain again.

Global WholeHealth Partners, Corp (OTC:GWHP) Announces New Purchase Agreement From RyZac Health as Order Size Increases of over 3 times larger from Initial Order, verified by letter from Michael Dwyer, the president of RyZac Health.

While discussing Covid-19 Antibody rapid tests and the market with Charles Strongo, CEO of Global WholeHealth Partners, Corp, RyZac Health CEO, Michael Dwyer said in his letter “your amazing 99.4% accuracy is outperforming most in the market.”

 

The market is growing because of the outbreak of the coronavirus (SARS CoV-2) pandemic, which has increased the demand for rapid testing across the world. As the number of people suffering from the viral infection increases, the demand for rapid testing, which allows detecting the virus quickly, is growing. The adoption of a population-wide testing approach, which includes household, individual testing, is one of the trends influencing the demand for Covid-19 diagnostics kits. The shift from symptomatic testing to mass testing in developed countries is another major factor affecting the market.

Global WholeHealth Partners recognizes that there is a crucial need for faster testing and faster results when it comes to fighting the COVID. Global WholeHealth Partners knows that the quicker the test results can be reviewed by a Front-Line Healthcare Worker, the quicker we can stop the spread of this disease.

With results in minutes versus hours or days with other diagnostic kits, the more lives that can be saved with the only FDA authorized COVID-19 POC serology Point of Care Test. With the new fingerstick test, healthcare providers can prick a patient’s finger and get results in minutes without having to wait for venous blood. Global WholeHealth Partners will be able to distribute these tests to more urgent cares, hospitals, and – to help curb the spread of CoViD19 SARS2.

As a third surge of the coronavirus threatens much of the United States, public health experts across the country say there still aren’t enough tests available to keep the virus under control.

About 30 million Covid-19 tests are given every month, according to estimates from The Atlantic magazine’s Covid Tracking Project. But studies have found that the U.S. would need millions more — 193 million a month, according to one report — to be effective.

The USA has the largest number of Covid-19 cases in the world and there is concern that this next wave of infections will be worse than the previous. Global WholeHealth Partners, Corp. is confident that its Covid-19 Rapid Test can make a difference through assisting companies, staff, and public places where transmission may occur with a reliable, accurate, and fast Rapid Test.

Global WholeHealth Partners Corp. provides cutting edge technology using In-vitro Diagnostic (IVD) Real-Time PCR Machines for detection of SARS-CoV-2 IgM/IgG antibodies in human serum, plasma, or whole blood. It has led the fight against vector borne terminal diseases such as Ebola, ZIKA, Dengue, Malaria, Influenza and Tuberculosis, Corona Viruses, and among other vector borne diseases. The company was founded on March 7, 2013 and is headquartered in San Clemente, CA.

GWHP develops, manufactures, and markets in vitro diagnostic (IVD) tests for OTC, or consumer-use as well as professional rapid diagnostic point-of-care (POC) test kits for hospitals, physicians’ offices, and medical clinics in the US and abroad. Notably, GWHP offers a CE Mark for its high quality, rapid antibody test for COVID-19 and an EUA filing with the FDA is pending approval. In the interim, the US Navy in California has been using the test during 2Q20 and the Company has the capacity to deliver hundreds of thousands of tests, ramping up to 1 million per day. Currently, the Company has 56 products FDA approved and many are Approved for OTC use, and 9 POC products approved by the FDA.

Disclaimer:

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.

Media Contact:

Name: Charles Strongo,

CEO, Global WholeHealth Partners Corp.

Email: investors@gwhpcorp.com

www.gwhpcorp.com

https://www.globenewswire.com/news-release/2020/12/11/2143930/0/en/The-global-COVID-19-diagnostics-market-by-revenue-is-expected-to-register-a-negative-CAGR-of-9-during-the-period-2021-2026.html

Forward-Looking Statements

This press release contains "forward-looking statements.” Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company's control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, risks and uncertainties associated with (i) market acceptance of our existing and new products, (ii) negative clinical trial results or lengthy product delays in key markets, (iii) an inability to secure regulatory approvals for the sale of our products, (iv) intense competition in the medical device industry from much larger, multinational companies, (v) product liability claims, (vi) product malfunctions, (vii) our limited manufacturing capabilities and reliance on subcontractors for assistance, (viii) insufficient or inadequate reimbursement by governmental and other third party payers for our products, (ix) our efforts to successfully obtain and maintain intellectual property protection covering our products, which may not be successful, (x) legislative or regulatory reform of the healthcare system in both the U.S. and foreign jurisdictions, (xi) our reliance on single suppliers for certain product components, (xii) the fact that we will need to raise additional capital to meet our business requirements in the future and that such capital raising may be costly, dilutive or difficult to obtain and (xiii) the fact that we conduct business in multiple foreign jurisdictions, exposing us to foreign currency exchange rate fluctuations, logistical and communications challenges, burdens and costs of compliance with foreign laws and political and economic instability in each jurisdiction. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is set forth in the Company's filings with the Securities and Exchange Commission (SEC), including the Company's Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's web site at http://www.sec.gov. The Company assumes no obligation to publicly update or revise its forward-looking statements as a result of new information, future events or otherwise.

More News

https://s3.amazonaws.com/findit-pictures/346732/0c6aa3c8-ed72-4136-8a3f-c2be169d06b8.jpg

Global WholeHealth Partners Corp. (OTC: GWHP) Signs a Binding MOU With Pan Probe Biotech and AvantGen to Develop the Newest COVID-19 Antigen Test on the Market: 8K Filed on 09/21/2021

Global WholeHealth Partners Corp. (OTC: GWHP) Signs a Binding MOU With Pan Probe Biotech and AvantGen to Develop the Newest COVID-19 Antigen Test on the Market: 8K Filed on 09/21/2021

Released On: 10/25/2021
Views: 2072

https://s3.amazonaws.com/findit-pictures/346732/1227abc5-6fbf-47b2-9223-db796dc4127b.jpg

Global WholeHealth Partners Provides Competitive Pricing on Bulk COVID-19 Testing Kits and PPE Supplies

Global WholeHealth Partners Provides Competitive Pricing on Bulk COVID-19 Testing Kits and PPE Supplies

Released On: 10/24/2021
Views: 2043

https://s3.amazonaws.com/findit-pictures/346732/51d1e0b2-0670-4465-8dda-6b378aea8edb.jpg

Global WholeHealth Partners Is The Trusted Provider of Wholesale PPE Supplies and COVID-19 Diagnostic Testing Kits

Global WholeHealth Partners Is The Trusted Provider of Wholesale PPE Supplies and COVID-19 Diagnostic Testing Kits

Released On: 10/22/2021
Views: 2089

https://s3.amazonaws.com/findit-pictures/346732/d816de95-0a0a-4ac3-b3a9-08f4dd73ca93.jpg

Order Medical Grade COVID-19 Diagnostic Testing Kits and PPE Supplies Wholesale Online from Global WholeHealth Partners

Order Medical Grade COVID-19 Diagnostic Testing Kits and PPE Supplies Wholesale Online from Global WholeHealth Partners

Released On: 10/20/2021
Views: 2063

https://s3.amazonaws.com/findit-pictures/346732/ddc67d17-21eb-4a8f-b664-75ea38acd819.jpg

Global WholeHealth Partners Corp (OTC: GWHP) Proudly Announces Its New Manufacturing Facility Which is Able to Triple the Production Volume for the Potential Sales from Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021

Global WholeHealth Partners Corp (OTC: GWHP) Proudly Announces Its New Manufacturing Facility Which is Able to Triple the Production Volume for the Potential Sales from Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021

Released On: 10/19/2021
Views: 2034

https://s3.amazonaws.com/findit-pictures/346732/cb571207-438e-40c1-9ed0-d6dcff5d2205.jpg

With COVID-19 Vaccination Rates Increasing Global WholeHealth Partners Continues To Source Premium PPE Supplies and Testing Kits

With COVID-19 Vaccination Rates Increasing Global WholeHealth Partners Continues To Source Premium PPE Supplies and Testing Kits

Released On: 10/18/2021
Views: 1983

https://s3.amazonaws.com/findit-pictures/346732/3ff71e6c-fbe8-47f1-8b66-8b61bfe19972.jpg

Global WholeHealth Partners Sources Superior PPE Supplies and COVID-19 Diagnostic Testing Kits Available for Wholesale Purchase

Global WholeHealth Partners Sources Superior PPE Supplies and COVID-19 Diagnostic Testing Kits Available for Wholesale Purchase

Released On: 10/16/2021
Views: 1965

https://s3.amazonaws.com/findit-pictures/346732/30ff7999-4bfb-4c2a-b1c0-610073f6e992.jpg

Global WholeHealth Partners Corp. (OTC: GWHP), is Approved to Sell Through Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch into the Retail Marketplace

Global WholeHealth Partners Corp. (OTC: GWHP), is Approved to Sell Through Walmart, Amazon, eBay and Shopify as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch into the Retail Marketplace

Released On: 10/14/2021
Views: 1923

https://s3.amazonaws.com/findit-pictures/346732/0bfc05a0-d80c-41ba-b540-2a526e5e047a.jpg

Purchase Superior COVID-19 Diagnostic Testing Kits And Personal Protective Equipment Online from Global WholeHealth Partners

Purchase Superior COVID-19 Diagnostic Testing Kits And Personal Protective Equipment Online from Global WholeHealth Partners

Released On: 10/14/2021
Views: 2564

https://s3.amazonaws.com/findit-pictures/346732/dd6a140a-8e00-40d3-930e-7eebb1fdc254.jpg

Global WholeHealth Partners Corp. (OTC: GWHP) Has Been Approved to Sell Its Products Through Walmart and Amazon as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch Into the Retail Marketplace

Global WholeHealth Partners Corp. (OTC: GWHP) Has Been Approved to Sell Its Products Through Walmart and Amazon as Stated in the 8K Filing 08/03/2021; Global's Newly Designed Tests Are Now Ready for the Launch Into the Retail Marketplace

Released On: 10/12/2021
Views: 1919

https://s3.amazonaws.com/findit-pictures/346732/d6e6a7c0-bdfd-41a3-8d23-997144be4b40.jpg

GWHP Corp Sources Wholesale PPE Supplies and COVID 19 Testing Kits In The Age of Coronavirus and Rising COVID-19 Cases

GWHP Corp Sources Wholesale PPE Supplies and COVID 19 Testing Kits In The Age of Coronavirus and Rising COVID-19 Cases

Released On: 10/10/2021
Views: 2417

https://s3.amazonaws.com/findit-pictures/346732/4196596c-799a-411a-8db2-7fe9b3a010c9.jpg

Order Bulk PPE Supplies and COVID 19 Diagnostic Testing Kits from Global WholeHealth Partners

Order Bulk PPE Supplies and COVID 19 Diagnostic Testing Kits from Global WholeHealth Partners

Released On: 10/4/2021
Views: 2330

https://s3.amazonaws.com/findit-pictures/346732/39582749-dda7-4268-9006-b6c69b820246.jpg

Shop Wholesale PPE Supplies and COVID-19 Tests Available from GWHP Corp Online Today

Shop Wholesale PPE Supplies and COVID-19 Tests Available from GWHP Corp Online Today

Released On: 9/30/2021
Views: 2017

https://s3.amazonaws.com/findit-pictures/346732/2bc3fb06-f611-4e21-b78b-74bb58d767c4.jpg

Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021

Global WholeHealth Partners Corp (OTC: GWHP) Partners With Pan Probe Biotech and AvantGen to Develop the Newest COVID19 Antigen Test on the Market; 8k Filed on 09/21/2021

Released On: 9/29/2021
Views: 1797

https://s3.amazonaws.com/findit-pictures/346732/21aa59a4-482c-494d-bf8c-e5b079389870.jpg

GWHP Continues to Source COVID-19 Tests and PPE Supplies As The Delta Variant Continues to Spread

GWHP Continues to Source COVID-19 Tests and PPE Supplies As The Delta Variant Continues to Spread

Released On: 9/27/2021
Views: 2263

https://s3.amazonaws.com/findit-pictures/346732/653cedbf-67da-43af-9a86-263830d6ef4b.jpg

Partnerships with Key Players Enables GWHP Corp To Source PPE Supplies and COVID-19 Diagnostic Testing Kits

Partnerships with Key Players Enables GWHP Corp To Source PPE Supplies and COVID-19 Diagnostic Testing Kits

Released On: 9/14/2021
Views: 2300

https://s3.amazonaws.com/findit-pictures/346732/c3508310-16cc-4b48-990f-260d0fccdb7f.jpg

Global WholeHealth Partners Corp (OTC:GWHP) Now Able to Sell Through Shopify’s Multibillion Dollar Online Platform as Stated in 8k Filing 08/05/21

Global WholeHealth Partners Corp (OTC:GWHP) Now Able to Sell Through Shopify’s Multibillion Dollar Online Platform as Stated in 8k Filing 08/05/21

Released On: 9/14/2021
Views: 1704

https://s3.amazonaws.com/findit-pictures/346732/7720d84b-58d3-49bc-9cae-2018b0b358c2.jpg

Global WholeHealth Partners Provides Wholesale PPE Supplies and COVID-19 Diagnostic Testing Kits

Global WholeHealth Partners Provides Wholesale PPE Supplies and COVID-19 Diagnostic Testing Kits

Released On: 9/12/2021
Views: 2342

Load More wait

Map

Global WholeHealth Partners

Get Directions

Global WholeHealth Partners

  • 1402 N El Camino Real
    San Clemente, California 92672
    USA
  • (714) 392-9752
  • Mon-Fri: 9:00am – 5:30pm PST
    Sat-Sun: Closed